Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Kuhle, J; Disanto, G; Dobson, R; Adiutori, R; Bianchi, L; Topping, J; Bestwick, JP; Meier, UC; Marta, M; Dalla Costa, G; Runia, T; Evdoshenko, E; Lazareva, N; Thouvenot, E; Iaffaldano, P; Direnzo, V; Khademi, M; Piehl, F; Comabella, M; Sombekke, M; Killestein, J; Hegen, H; Rauch, S; D'Alfonso, S; Alvarez-Cermeño, JC; Kleinová, P; Horáková, D; Roesler, R; Lauda, F; Llufriu, S; Avsar, T; Uygunoglu, U; Altintas, A; Saip, S; Menge, T; Rajda, C; Bergamaschi, R; Moll, N; Khalil, M; Marignier, R; Dujmovic, I; Larsson, H; Malmestrom, C; Scarpini, E; Fenoglio, C; Wergeland, S; Laroni, A; Annibali, V; Romano, S; Martínez, AD; Carra, A; Salvetti, M; Uccelli, A; Torkildsen, Ø; Myhr, KM; Galimberti, D; Rejdak, K; Lycke, J; Frederiksen, JL; Drulovic, J; Confavreux, C; Brassat, D; Enzinger, C; Fuchs, S; Bosca, I; Pelletier, J; Picard, C; Colombo, E; Franciotta, D; Derfuss, T; Lindberg, R; Yaldizli, Ö; Vécsei, L; Kieseier, BC; Hartung, HP; Villoslada, P; Siva, A; Saiz, A; Tumani, H; Havrdová, E; Villar, LM; Leone, M; Barizzone, N; Deisenhammer, F; Teunissen, C; Montalban, X; Tintoré, M; Olsson, T; Trojano, M; Lehmann, S; Castelnovo, G; Lapin, S; Hintzen, R; Kappos, L; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, SV; Giovannoni, G.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Mult Scler. 2015; 21(8):1013-1024
Doi: 10.1177/1352458514568827
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Enzinger Christian
- Fuchs Siegrid
- Khalil Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort. Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, cerebrospinal fluid (CSF) oligoclonal bands (OCBs), CSF IgG index, CSF cell count, serum 25-hydroxyvitamin D3 (25-OH-D), cotinine and IgG titres against Epstein-Barr nuclear antigen 1 (EBNA-1) and cytomegalovirus were tested for association with risk of CDMS. At median follow-up of 4.31 years, 623 CIS cases converted to CDMS. Predictors of conversion in multivariable analyses were OCB (HR = 2.18, 95% CI = 1.71-2.77, p < 0.001), number of T2 lesions (two to nine lesions vs 0/1 lesions: HR = 1.97, 95% CI = 1.52-2.55, p < 0.001; >9 lesions vs 0/1 lesions: HR = 2.74, 95% CI = 2.04-3.68, p < 0.001) and age at CIS (HR per year inversely increase = 0.98, 95% CI = 0.98-0.99, p < 0.001). Lower 25-OH-D levels were associated with CDMS in univariable analysis, but this was attenuated in the multivariable model. OCB positivity was associated with higher EBNA-1 IgG titres. We validated MRI lesion load, OCB and age at CIS as the strongest independent predictors of conversion to CDMS in this multicentre setting. A role for vitamin D is suggested but requires further investigation. © The Author(s), 2015.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Cohort Studies -
- Disease Progression -
- Female -
- Follow-Up Studies -
- Humans -
- Immunoglobulin G - analysis
- Magnetic Resonance Imaging -
- Male -
- Multiple Sclerosis - cerebrospinal fluid
- Multiple Sclerosis - pathology
- Nuclear Proteins - analysis
- Oligoclonal Bands - genetics
- Predictive Value of Tests -
- Prognosis -
- Risk Assessment -
- Survival Analysis -
- Vitamin D - blood
- Find related publications in this database (Keywords)
- Clinically definite multiple sclerosis (CDMS)
- clinically isolated syndrome (CIS)
- Epstein-Barr nuclear antigen 1 (EBNA-1)
- oligoclonal bands (OCBs)
- serum 25-hydroxyvitamin D3 (25-OH-D)